Ipratropium Bromide 0.02% Inhalation Solution 0.5 mg Per 2.5 mL Vials, 30 Count (Rx)

Ipratropium Bromide Inhalation Solution 0.02% is a bronchodilator used to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. It works by relaxing and opening the airways in the lungs, making it easier to breathe. This solution is typically administered through a nebulizer, offering fast relief from symptoms like wheezing, shortness of breath, and chest tightness. By targeting the muscles around the airways, it helps improve airflow and lung function, providing crucial support for managing chronic respiratory ailments.

Mylan Pharmaceuticals presents Ipratropium Bromide 0.02% Inhalation Solution, a reliable therapeutic choice for individuals with chronic obstructive pulmonary disease (COPD) or other respiratory conditions. Designed to ease breathing and improve lung function, this solution delivers targeted relief from bronchospasms, helping patients maintain their daily activities with greater ease. Packaged in convenient, single-dose vials, Mylan ensures both quality and consistency in every breath you take toward better respiratory health.

Product Details and Features:

Active Ingredient: Ipratropium Bromide 0.5 mg per 2.5 mL vial; an anticholinergic bronchodilator.
Pack Size: Contains 30 single-use vials for precise dosing and ease of use at home or on-the-go.
Convenient Delivery: Designed for nebulization, ensuring direct delivery to the lungs for rapid effect.
Stable and Sterile: Individually packaged vials maintain sterility and potency until use.
Broad Application: Effective for use in chronic conditions like COPD, chronic bronchitis, and emphysema.

Mechanism of Action:

Ipratropium Bromide acts as an anticholinergic agent, blocking the muscarinic receptors in the airway smooth muscle. This inhibition prevents acetylcholine from binding to receptors, leading to bronchodilation. As a result, the airways expand, airflow improves, and breathing becomes easier for patients with obstructive airway diseases.

Directions for Use:

1. Preparation: Use as prescribed by your physician. Connect the vial to a nebulizer suitable for inhalation therapy.
2. Dosage: One vial is typically used 3 to 4 times a day at evenly spaced intervals, but follow physician’s specific instructions.
3. Administration: Gently twist off the top of the vial, squeeze contents into the nebulizer reservoir, and follow nebulizer instructions for use.
4. Completion: Use immediately after opening and discard any leftover solution. Do not store opened vials for future use.

Warnings:

• For Respiratory Use Only: Not for injection or oral consumption.
  
• Allergy Alert: Do not use if you have a hypersensitivity to Ipratropium or atropine and its derivatives.
  
• Consult Health Providers: If experiencing glaucoma, prostate enlargement, or bladder blockage.
  
• Immediate Care: Seek medical attention if a paradoxical bronchospasm (worsened breathing) occurs.

Potential Side Effects:

• Common Effects: Dry mouth, cough, or irritation in the throat or airways.
  
• Less Common Effects: Dizziness, headache, or gastrointestinal discomfort may occur.
  
• Severe Effects: Serious allergic reactions, including rash, swelling, or difficulty breathing, require immediate medical intervention.

Empower your respiratory health confidently with Mylan Pharmaceuticals' Ipratropium Bromide 0.02% Inhalation Solution, designed to support clearer, easier breathing for individuals facing chronic respiratory challenges. Trust in Mylan's commitment to high-quality, reliable medication management so you can focus on living life fully with unparalleled peace of mind.